Neonatology Department, The First Hospital of Qinhuangdao, No. 258, Wenhua Road, Haigang District, Qinhuangdao, 066000, Hebei, China.
Endocrine Department, The First Hospital of Qinhuangdao, Qinhuangdao, Hebei, China.
BMC Pediatr. 2023 May 20;23(1):248. doi: 10.1186/s12887-023-04075-1.
To study the effects of vitamin D supplementation on physical growth and neurologic development of very preterm infants receiving nesting intervention in the neonatal intensive care unit (NICU).
A total of 196 preterm infants had been hospitalized in NICU with the gestational age (GA) between 28 and 32 weeks. Among them, 98 preterm infants received nesting intervention, and the other 98 cases received both nesting and vitamin D supplementation (400 IU). The interventions were continued until 36 weeks postmenstrual age (PMA). The 25(OH)D serum levels, anthropometric parameters, and Premie-Neuro (PN) scores were compared at 36 weeks PMA.
Higher median serum level of 25(OH)D was found in the nesting + vitamin D [38.40 ng/mL (IQR: 17.20 ~ 70.88) ng/mL] as compared to the nesting group [15.95 ng/mL (IQR: 10.80 ~ 24.30) ng/mL] at 36 weeks PMA. Besides, infants receiving combined nesting intervention and vitamin D supplementation had less proportion of vitamin D deficiency [VDD, 25(OH)D levels < 20 ng/mL] than those receiving nesting intervention alone. After intervention, the anthropometric parameters of infants, including weight, length, BMI and head circumference were improved in the nesting + vitamin D group as compared to the nesting group at 36 weeks PMA, with higher scores of neurological, movement and responsiveness.
Vitamin D supplementation effectively decreased the prevalence of VDD and led to higher concentrations of 25(OH)D at 36 weeks PMA. This was one more study that supported the necessity of vitamin D supplementation to improve physical growth and neurologic development of preterm-born newborns who received nesting intervention in the NICU.
研究维生素 D 补充对接受鸟巢干预的新生儿重症监护病房(NICU)中极早产儿体格生长和神经发育的影响。
共有 196 例胎龄(GA)为 28 至 32 周的早产儿在 NICU 住院。其中 98 例早产儿接受鸟巢干预,另 98 例接受鸟巢干预加维生素 D 补充(400IU)。干预持续至出生后 36 周(PMA)。比较两组早产儿在 36 周 PMA 时血清 25(OH)D 水平、体格生长参数和 Premie-Neuro(PN)评分。
鸟巢+维生素 D 组早产儿 36 周 PMA 时血清 25(OH)D 中位数水平[38.40 ng/ml(IQR:17.2070.88)ng/ml]明显高于鸟巢组[15.95 ng/ml(IQR:10.8024.30)ng/ml]。此外,与仅接受鸟巢干预的早产儿相比,联合接受鸟巢干预和维生素 D 补充的早产儿维生素 D 缺乏[25(OH)D 水平<20ng/ml]的比例更低。干预后,鸟巢+维生素 D 组早产儿的体重、身长、BMI 和头围等体格生长参数在 36 周 PMA 时较鸟巢组均有改善,且神经、运动和反应评分更高。
维生素 D 补充有效降低了维生素 D 缺乏的发生率,并在 36 周 PMA 时使 25(OH)D 浓度升高。这进一步支持了维生素 D 补充对改善接受鸟巢干预的 NICU 极早产儿体格生长和神经发育的必要性。